Division of Pediatric Hematology and Oncology

Michael DeBaun receives Paragon Award from the Doris Duke Charitable Foundation

Vanderbilt’s Michael DeBaun, MD, MS, MPH, has received the Paragon Award for “Innovative Improvements to Clinical Care or Healthcare Delivery” from the Doris Duke Charitable Foundation (DDF).

Multi-institutional study of Wilms tumor facilitates enrollment, optimizes treatment

Multi-institutional study finds that enrollment and outcomes were similar across racial and ethnic groups for children participating in therapeutic trials for Wilms tumor — the most common pediatric kidney cancer worldwide.

Debra Friedman named deputy director of Vanderbilt-Ingram Cancer Center

Internationally recognized cancer survivorship expert Debra Friedman, MD, MS, has been named deputy director of Vanderbilt-Ingram Cancer Center

Debra Friedman, MD, MS, center, with representatives from Hyundai Motor America and local dealerships. (photo by Donn Jones)

Debra Friedman receives Hyundai Hope On Wheels Impact Award

Debra Friedman, MD, MS, has been awarded a $100,000 Hyundai Hope On Wheels Impact Award to examine outcomes in pediatric, adolescent and young adult sarcoma patients and survivors.

On hand for a recent celebration of the new research fund were Debra Friedman, MD, MS, left, and Brianna Smith, MD, MS, (holding the plaque) and, from right, Larisa and Phillip Featherstone with their daughters Lily, Sophie and Sophia, and Carol and Ron Johnston.

Family’s gift will support pediatric cancer research

Lily Hensiek’s family has made a new $1 million commitment to endow the Lily’s Garden Discovery Researcher Fund in the Division of Pediatric Hematology and Oncology in the Department of Pediatrics at Vanderbilt University Medical Center.

High-dose flu vaccine beneficial for pediatric stem cell transplant patients

Vanderbilt was the lead site for an influenza vaccine study in pediatric allogeneic hematopoietic stem cell transplant recipients that may lead to a change in the current flu vaccine recommendations in this vulnerable population.

1 2 3 4